While still in an early stage, interest in testing asymptomatic patients is growing as drug developers explore treating ...

The test can now be used for clinician-collected primary screening to detect infections that can lead to cervical cancer.

Under the deal, Sysmex will exclusively sell Fujirebio's Lumipulse immunoassay systems and dementia-related tests in certain geographies.

NEW YORK – Oncologists see molecular residual disease (MRD) testing and multi-cancer early detection (MCED) assays as the most significant future opportunities in cancer diagnostics, according to a ...

The award is the first following a funding announcement last year to support typhoid fever diagnostic test development.

NEW YORK – iFast Diagnostics said on Wednesday that it has received the UK Conformity Assessed (UKCA) mark for its iFast One ultra-rapid antimicrobial susceptibility test (AST) system. Clinicians in ...

While labs overwhelmingly welcomed the ruling, it could make it more difficult for firms that want FDA's imprimatur for LDTs ...

The firm saw a 8 decline in diagnostics revenue and projected a more pronounced decline in fiscal Q2, due primarily to volume-based pricing headwinds.

The agency said that impurities in the company's Safe-T-Fill EDTA tubes may be related to false positive lead testing results reported by users of Magellan Diagnostics' lead detection tests.